A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn HDFN

Project: Research project

Project Details

StatusActive
Effective start/end date4/5/244/4/29

Funding

  • Janssen Pharmaceutical Research & Develo: $9,275.38